We use cookies to improve your experience and for marketing. Read our cookie policy or manage cookies.

Accept essential cookies
Accept all cookies
Sign in
Sign in
Companies → FOSUN INTERNATIONAL LIMITED
Save to list
Remove

FOSUN INTERNATIONAL LIMITED

Hong Kong SAR, Central District
Report a bug?
Claim ownership and edit
Description
by AI
Fosun International Limited is a Chinese multinational company with headquarters in Shanghai. It has four main business segments: insurance, investment, industrial operations, and asset management. Fosun International was founded in 1992 and is listed on the Hong Kong Stock Exchange and the Shanghai Stock Exchange. The company's insurance business is conducted through its subsidiaries, Fosun Insurance Group and Peak Reinsurance Company. Fosun Investment Group is the company's investment arm, and it manages a portfolio of investments in various sectors, including financial services, healthcare, and real estate. Fosun Industrial Operations is the company's industrial operations arm, and it manufactures and sells a variety of products, including pharmaceuticals, chemicals, and steel. Fosun Asset Management is the company's asset management arm, and it manages a portfolio of investments on behalf of clients. Fosun International has a global presence, with operations in over 30 countries and regions. The company has over 90,000 employees worldwide. According to Forbes, Fosun International was ranked 171st on the Global 2000 list in 2021, making it the largest Chinese company on the list that year. The company has also been recognized for its corporate social responsibility efforts, and it was ranked 10th on the Asia Corporate Governance Association's list of Asia's Top 50 Corporate Governance Companies in 2021. Fosun International's website provides a detailed overview of the company's business operations and performance: https://www.fosun.com/
Industries
SIC
Address:

Rm 808 8/F ICBC TWR 3 GARDEN RD Central District Hong Kong

Website:
Revenue
Recent news:

Fosun Secures $500M Loan After Warning of 23.5 Billion Yuan Loss

Refinancing backed by HSBC, JPMorgan and Natixis supports repayment of a $520 million loan due in April.

Source: GuruFocus.com Mar 20, 2026

Assessing Fosun International (SEHK:656) Valuation After Recent Share Price Weakness

Fosun International (SEHK:656) is back on investors’ radar after recent share price weakness. The stock closed at HK$4.12 and has shown negative returns over the past month and past 3 months. See our latest analysis for Fosun International. That recent 6.2% 30 day share price decline and 14.2% 90 day share price decline come on top of a 1 year total shareholder return of about 1% and a 5 year total shareholder return of roughly 62% lower. This suggests sentiment has been weak rather than...

Source: Simply Wall St. Feb 2, 2026

Deutsche Bank and DWS explore investment in life insurer Frankfurter Leben

Such a move would mark Deutsche Bank’s return to the life insurance space after it withdrew from the sector around ten years ago.

Source: Life Insurance International Jan 30, 2026

GLP-1 Weight-Loss Drugs for Obese Cats Considered by Pet Owners and Biotech

Article explores the emerging market for GLP-1-based weight-loss drugs to treat obesity in cats, driven by pet owner concerns and recent biotech developments.

Source: IndexBox Jan 7, 2026

Why One Investor Sold $6 Million of the MSCI China ETF Amid a Nearly 30% Run

After a strong rebound in Chinese equities, one investor chose to step aside from this ETF entirely.

Source: Motley Fool Dec 29, 2025

Fosun International (SEHK:656): Assessing Valuation After a Gradual Share Price Rebound

Fosun International (SEHK:656) has quietly turned in a stronger stretch of performance this year, with the share price up about 13% year to date even as the past 3 months remain slightly negative. See our latest analysis for Fosun International. That recent 7 day share price return of 2.26% and 1 month share price return of 3.75%, against a still negative 3 year total shareholder return, suggests momentum is tentatively rebuilding after a tougher stretch. If Fosun's rebound has caught your...

Source: Simply Wall St. Dec 5, 2025

OTC - Delayed Quote - USD
FOSUY
12.46 0.00 (0.00%)
At close March 20 20:00 UTC
Candle
Line
1D
5D
1M
6M
1Y
5Y
Financial Statistics
Valuation Measures
Current
Quarterly
As of 03/21/2026
Market Cap: 3.94 B
Enterprise Value: 19.31 B
Trailing P/E: 50.71
Forward P/E: N/A
PEG Ratio (5yr expected): N/A
Price/Sales (ttm): 0.15
Price/Book (mrq): 0.24
Enterprise Value/Revenue: 0.73
Enterprise Value/EBITDA: 10.05
Financial Highlights
Profitability and Income Statement
Profit Margin: -2.43%
Return on Assets (ttm): -0.58%
Return on Equity (ttm): -1.01%
Revenue (ttm): 181.59 B
Net Income Avi to Common (ttm): -4.41 B
Diluted EPS (ttm): -1.96
Balance Sheet and Cash Flow
Total Cash (mrq): 111.54 B
Total Debt/Equity (mrq): 112.55%
Levered Free Cash Flow (ttm): -3.43 B
Company is likely to buy
Company is likely to sell
Disclaimer:

IndexBox is not affiliated with, associated with, or endorsed by this company in any way. The information provided on this page, including company details, is solely for informational purposes. IndexBox makes no representations or warranties about the accuracy or completeness of the information provided.

All data and information is provided “as is” for informational purposes only, and is not intended for trading purposes or financial, investment, tax, legal, accounting or other advice. Please consult your broker or financial representative to verify pricing before executing any trade. IndexBox is not an investment adviser, financial adviser or a securities broker. None of the data and information constitutes investment advice nor an offering, recommendation or solicitation by IndexBox to buy, sell or hold any security or financial product, and IndexBox makes no representation (and has no opinion) regarding the advisability or suitability of any investment.